US Stock MarketDetailed Quotes

AKYA Akoya Biosciences

Watchlist
  • 2.660
  • +0.040+1.53%
Close Jan 8 16:00 ET
  • 2.680
  • +0.020+0.75%
Post 19:57 ET
131.84MMarket Cap-2.29P/E (TTM)

Akoya Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.70%-9.26M
6.46%-11.04M
-5.40%-20.82M
4.85%-50.9M
44.20%-5.58M
-13.00%-13.75M
11.82%-11.8M
-10.18%-19.76M
-48.32%-53.5M
-70.94%-10.01M
Net income from continuing operations
18.45%-10.53M
36.79%-13.15M
-24.90%-23.48M
10.36%-63.32M
42.77%-10.8M
27.73%-12.92M
-18.91%-20.8M
-14.65%-18.8M
-64.53%-70.64M
-6.80%-18.88M
Operating gains losses
----
----
----
----
----
----
----
----
-67.46%82K
--0
Depreciation and amortization
-29.15%1.83M
-7.71%1.93M
-3.30%2.05M
24.35%8.89M
10.78%2.11M
32.85%2.58M
23.49%2.09M
31.01%2.12M
49.19%7.15M
38.36%1.9M
Deferred tax
--38K
--0
--37K
-245.71%-51K
20.31%-51K
--0
--0
--0
122.58%35K
46.22%-64K
Other non cash items
-105.14%-55K
-0.95%1.26M
49.25%1.5M
203.18%7.63M
18.06%4.29M
19.96%1.07M
154.86%1.27M
228.85%1M
0.68%2.52M
221.22%3.63M
Change In working capital
69.24%-2.39M
-559.15%-3.79M
-27.36%-8.22M
-9,562.75%-14.48M
-181.40%-1.09M
-1,001.63%-7.76M
-72.18%825K
-28.69%-6.45M
103.35%153K
-83.31%1.34M
-Change in receivables
216.66%3.77M
-4,802.60%-3.62M
197.88%3.15M
-2,449.12%-7.27M
14.39%-898K
-280.25%-3.23M
-90.86%77K
-71.87%-3.21M
90.42%-285K
-751.55%-1.05M
-Change in inventory
73.89%-782K
41.48%-2.29M
-5,235.77%-7.31M
-17.83%-6.33M
150.64%708K
-2,032.26%-3M
-111.82%-3.91M
94.01%-137K
-16.12%-5.37M
40.66%-1.4M
-Change in prepaid assets
-138.54%-79K
592.57%862K
-99.84%4K
182.83%2.26M
-127.54%-290K
-74.60%205K
-296.63%-175K
318.68%2.52M
109.08%798K
361.84%1.05M
-Change in payables and accrued expense
-307.45%-4.32M
-64.97%1.7M
46.28%-3.16M
-158.05%-2.33M
-105.49%-236K
47.55%-1.06M
128.34%4.85M
-1,461.27%-5.89M
-63.02%4.02M
-55.56%4.3M
-Change in other current liabilities
-2.81%-622K
-1.14%-532K
-2.41%-552K
-44.76%-2.29M
76.06%-623K
-70.90%-605K
-129.73%-526K
-35.77%-539K
---1.58M
---2.6M
-Change in other working capital
-354.55%-350K
-82.05%91K
-142.15%-341K
-42.30%1.49M
-76.06%249K
-115.91%-77K
10.70%507K
35.51%809K
168.09%2.58M
220.99%1.04M
Cash from discontinued investing activities
Operating cash flow
32.70%-9.26M
6.46%-11.04M
-5.40%-20.82M
4.85%-50.9M
44.20%-5.58M
-13.00%-13.75M
11.82%-11.8M
-10.18%-19.76M
-48.32%-53.5M
-70.94%-10.01M
Investing cash flow
Cash flow from continuing investing activities
1,664.78%13.02M
736.26%9.05M
-887.88%-48.82M
123.77%3.35M
-102.68%-594K
-111.45%-832K
96.64%-1.42M
644.46%6.2M
-176.38%-14.08M
1,721.32%22.13M
Net PPE purchase and sale
47.84%-434K
88.05%-170K
-0.75%-810K
49.99%-3.65M
31.65%-594K
77.72%-832K
9.02%-1.42M
29.35%-804K
-43.40%-7.31M
36.34%-869K
Net investment purchase and sale
--13.45M
--9.22M
-785.81%-48.01M
203.34%7M
--0
--0
--0
--7M
---6.77M
--23M
Cash from discontinued investing activities
Investing cash flow
1,664.78%13.02M
736.26%9.05M
-887.88%-48.82M
123.77%3.35M
-102.68%-594K
-111.45%-832K
96.64%-1.42M
644.46%6.2M
-176.38%-14.08M
1,721.32%22.13M
Financing cash flow
Cash flow from continuing financing activities
-6.38%-150K
-104.59%-2.13M
-5.97%-444K
97.88%56.84M
7.86%11.08M
-101.43%-141K
434.52%46.33M
-490.14%-419K
-79.04%28.73M
6,792.62%10.27M
Net issuance payments of debt
5.14%-166K
0.00%-173K
-22.30%-181K
-65.48%10.57M
-0.15%11.07M
-101.78%-175K
-101.76%-173K
-17.46%-148K
9,612.11%30.63M
15,498.61%11.09M
Net common stock issuance
--0
----
----
--47.97M
---28K
---76K
----
----
--0
--0
Proceeds from stock option exercised by employees
-85.45%16K
-83.92%23K
-37.93%36K
-22.60%346K
-81.38%35K
175.00%110K
-12.80%143K
5.45%58K
13.45%447K
-14.93%188K
Net other financing activities
--0
-15.23%-1.98M
9.12%-299K
13.06%-2.04M
--0
--0
---1.71M
---329K
-47.80%-2.35M
---1.01M
Cash from discontinued financing activities
Financing cash flow
-6.38%-150K
-104.59%-2.13M
-5.97%-444K
97.88%56.84M
7.86%11.08M
-101.43%-141K
434.52%46.33M
-490.14%-419K
-79.04%28.73M
6,792.62%10.27M
Net cash flow
Beginning cash position
-89.72%9.63M
-77.31%13.74M
12.47%83.82M
-34.26%74.53M
51.38%78.93M
98.48%93.65M
-35.75%60.55M
-34.26%74.53M
547.60%113.38M
-56.71%52.14M
Current changes in cash
124.53%3.61M
-112.42%-4.11M
-401.29%-70.09M
123.92%9.29M
-78.12%4.9M
-397.19%-14.73M
170.34%33.1M
26.96%-13.98M
-140.52%-38.85M
416.75%22.39M
End cash Position
-83.22%13.24M
-89.72%9.63M
-77.31%13.74M
12.47%83.82M
12.47%83.82M
51.38%78.93M
98.48%93.65M
-35.75%60.55M
-34.26%74.53M
-34.26%74.53M
Free cash flow
33.56%-9.69M
15.24%-11.21M
-5.21%-21.63M
10.36%-54.55M
43.20%-6.18M
8.62%-14.59M
11.53%-13.23M
-7.82%-20.56M
-47.85%-60.86M
-50.66%-10.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.70%-9.26M6.46%-11.04M-5.40%-20.82M4.85%-50.9M44.20%-5.58M-13.00%-13.75M11.82%-11.8M-10.18%-19.76M-48.32%-53.5M-70.94%-10.01M
Net income from continuing operations 18.45%-10.53M36.79%-13.15M-24.90%-23.48M10.36%-63.32M42.77%-10.8M27.73%-12.92M-18.91%-20.8M-14.65%-18.8M-64.53%-70.64M-6.80%-18.88M
Operating gains losses ---------------------------------67.46%82K--0
Depreciation and amortization -29.15%1.83M-7.71%1.93M-3.30%2.05M24.35%8.89M10.78%2.11M32.85%2.58M23.49%2.09M31.01%2.12M49.19%7.15M38.36%1.9M
Deferred tax --38K--0--37K-245.71%-51K20.31%-51K--0--0--0122.58%35K46.22%-64K
Other non cash items -105.14%-55K-0.95%1.26M49.25%1.5M203.18%7.63M18.06%4.29M19.96%1.07M154.86%1.27M228.85%1M0.68%2.52M221.22%3.63M
Change In working capital 69.24%-2.39M-559.15%-3.79M-27.36%-8.22M-9,562.75%-14.48M-181.40%-1.09M-1,001.63%-7.76M-72.18%825K-28.69%-6.45M103.35%153K-83.31%1.34M
-Change in receivables 216.66%3.77M-4,802.60%-3.62M197.88%3.15M-2,449.12%-7.27M14.39%-898K-280.25%-3.23M-90.86%77K-71.87%-3.21M90.42%-285K-751.55%-1.05M
-Change in inventory 73.89%-782K41.48%-2.29M-5,235.77%-7.31M-17.83%-6.33M150.64%708K-2,032.26%-3M-111.82%-3.91M94.01%-137K-16.12%-5.37M40.66%-1.4M
-Change in prepaid assets -138.54%-79K592.57%862K-99.84%4K182.83%2.26M-127.54%-290K-74.60%205K-296.63%-175K318.68%2.52M109.08%798K361.84%1.05M
-Change in payables and accrued expense -307.45%-4.32M-64.97%1.7M46.28%-3.16M-158.05%-2.33M-105.49%-236K47.55%-1.06M128.34%4.85M-1,461.27%-5.89M-63.02%4.02M-55.56%4.3M
-Change in other current liabilities -2.81%-622K-1.14%-532K-2.41%-552K-44.76%-2.29M76.06%-623K-70.90%-605K-129.73%-526K-35.77%-539K---1.58M---2.6M
-Change in other working capital -354.55%-350K-82.05%91K-142.15%-341K-42.30%1.49M-76.06%249K-115.91%-77K10.70%507K35.51%809K168.09%2.58M220.99%1.04M
Cash from discontinued investing activities
Operating cash flow 32.70%-9.26M6.46%-11.04M-5.40%-20.82M4.85%-50.9M44.20%-5.58M-13.00%-13.75M11.82%-11.8M-10.18%-19.76M-48.32%-53.5M-70.94%-10.01M
Investing cash flow
Cash flow from continuing investing activities 1,664.78%13.02M736.26%9.05M-887.88%-48.82M123.77%3.35M-102.68%-594K-111.45%-832K96.64%-1.42M644.46%6.2M-176.38%-14.08M1,721.32%22.13M
Net PPE purchase and sale 47.84%-434K88.05%-170K-0.75%-810K49.99%-3.65M31.65%-594K77.72%-832K9.02%-1.42M29.35%-804K-43.40%-7.31M36.34%-869K
Net investment purchase and sale --13.45M--9.22M-785.81%-48.01M203.34%7M--0--0--0--7M---6.77M--23M
Cash from discontinued investing activities
Investing cash flow 1,664.78%13.02M736.26%9.05M-887.88%-48.82M123.77%3.35M-102.68%-594K-111.45%-832K96.64%-1.42M644.46%6.2M-176.38%-14.08M1,721.32%22.13M
Financing cash flow
Cash flow from continuing financing activities -6.38%-150K-104.59%-2.13M-5.97%-444K97.88%56.84M7.86%11.08M-101.43%-141K434.52%46.33M-490.14%-419K-79.04%28.73M6,792.62%10.27M
Net issuance payments of debt 5.14%-166K0.00%-173K-22.30%-181K-65.48%10.57M-0.15%11.07M-101.78%-175K-101.76%-173K-17.46%-148K9,612.11%30.63M15,498.61%11.09M
Net common stock issuance --0----------47.97M---28K---76K----------0--0
Proceeds from stock option exercised by employees -85.45%16K-83.92%23K-37.93%36K-22.60%346K-81.38%35K175.00%110K-12.80%143K5.45%58K13.45%447K-14.93%188K
Net other financing activities --0-15.23%-1.98M9.12%-299K13.06%-2.04M--0--0---1.71M---329K-47.80%-2.35M---1.01M
Cash from discontinued financing activities
Financing cash flow -6.38%-150K-104.59%-2.13M-5.97%-444K97.88%56.84M7.86%11.08M-101.43%-141K434.52%46.33M-490.14%-419K-79.04%28.73M6,792.62%10.27M
Net cash flow
Beginning cash position -89.72%9.63M-77.31%13.74M12.47%83.82M-34.26%74.53M51.38%78.93M98.48%93.65M-35.75%60.55M-34.26%74.53M547.60%113.38M-56.71%52.14M
Current changes in cash 124.53%3.61M-112.42%-4.11M-401.29%-70.09M123.92%9.29M-78.12%4.9M-397.19%-14.73M170.34%33.1M26.96%-13.98M-140.52%-38.85M416.75%22.39M
End cash Position -83.22%13.24M-89.72%9.63M-77.31%13.74M12.47%83.82M12.47%83.82M51.38%78.93M98.48%93.65M-35.75%60.55M-34.26%74.53M-34.26%74.53M
Free cash flow 33.56%-9.69M15.24%-11.21M-5.21%-21.63M10.36%-54.55M43.20%-6.18M8.62%-14.59M11.53%-13.23M-7.82%-20.56M-47.85%-60.86M-50.66%-10.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Toll Brothers
TOL
+2.56%
Meritage Homes
MTH
+2.34%
Taylor Morrison Home
TMHC
+1.58%
D.R. Horton
DHI
+1.49%
KB Home
KBH
+1.35%

Unlock the Full List